CHICAGO—At the world’s largest oncology conference, Ozempic, a diabetes drug, found its way to the center of the conversation. As thousands of attendees bounced between presentations at the American ...

The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the science - and culture - of weight loss. Now a growing body of research is raising ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

The arrival of summer means beach season is calling for many, which may lead some to chase the perfect swimsuit physique. A 2025 Gallup poll showed that 52% of Americans want to lose weight but that ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Lung cancer is among the conditions that may be affected. GLP-1 medications such as Wegovy, ...

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual meeting. Limited time: ...

The use of GLP-1 medications for weight loss continues to rise. One drawback associated with GLP-1 medications is that weight loss not only includes fat loss, but muscle loss as well. A new study ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. Some of pop culture’s most recognizable faces are no ...

When it comes to treating obesity, type 2 diabetes, and other chronic health conditions, GLP-1 agonist drugs—such as Ozempic, Zepbound, and Wegovy—have been a game changer for literally millions of ...